$KEY

Ramani Mohit sold $568K of KEY

Ramani Mohit (Chief Risk Officer) sold 25,000 shares of KEYCORP /NEW/ (KEY) at $22.74 ($0.57M total) on 2026-07-22.

Original reporting
SEC EDGAR · Ramani Mohit
Published Jul 24, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KEY
Neutral
medium confidence
Mentioned
$KEY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEYNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings. It may marginally influence sentiment but does not introduce new fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale alone is unlikely to drive a sustained repricing.

03

What to watch

The filing does not state a 10b5-1 plan, but it also does not provide context for why the sale occurred, limiting inference about future risk or earnings.

Relevance 5/10Novelty 4/10Timing: Filed 2026-07-24 after-hours; reflects sale executed 2026-07-22.

Background

This is an SEC Form 4 insider transaction disclosure for KEYCORP, reported by Chief Risk Officer Ramani Mohit.

Company-level read

Ticker impact

$KEYNeutralMedium confidence
Context

SEC Form 4 shows KEYCORP Chief Risk Officer Ramani Mohit sold 25,000 shares at $22.74 on 2026-07-22, totaling $568,500.

Expected impact

Likely limited near-term impact; any effect should be small and sentiment-driven rather than trend-changing.

Evidence & confidence

The filing is a primary-source insider transaction, but it provides no new company-specific operating, regulatory, or financial datapoint. Insider sales can be planned or tax-related; absence of a stated 10b5-1 plan adds some uncertainty but still lacks evidence of business deterioration.

Market effects

Minimal. One insider sale does not materially change bank-sector fundamentals or risk outlook.

None indicated.

None indicated.

Counterpoint

The sale could be non-informational (tax, diversification, or personal liquidity), so price reaction may be overstated.

Key entities

  • KEYCORP /NEW/

    Subject of the Form 4 insider transaction disclosure.

  • Ramani Mohit

    Chief Risk Officer who sold 25,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JPMMed

Major U.S. banks raise prime rate after Fed rate hike

Major U.S. banks, including JPMorgan, Bank of America, and others, raised their prime lending rate to 7% after the Federal Reserve's quarter-point rate hike. The move increases borrowing costs for consumers and businesses. Bank stocks fell, with BofA down 2.7%, Citi 2.4%, and JPMorgan 1%. Rate hikes may boost bank earnings but could also slow economic activity and impact credit quality.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$KEYMed

KeyCorp Raises 2026 Revenue Outlook: What's Driving It?

KeyCorp (KEY) raised its 2026 revenue outlook to 8% growth, up from 7-8%, citing strong loan growth, fee-based business momentum, and the Clearwater acquisition. Non-interest income is now expected to grow 4-5%, with adjusted non-interest income projected to increase 6-7%. The company also affirmed a 20%+ sequential rise in third-quarter investment-banking fees. KeyCorp anticipates 4-5% average loan growth and 9-11% net interest income growth for 2026, supported by solid loan demand and deposit

$KEYMedAI 8/10

FCA clears acquisition of Clearwater UK by KeyCorp

The UK Financial Conduct Authority cleared KeyCorp’s acquisition of corporate finance advisory firm Clearwater UK. KeyCorp completed the deal on 4 August 2026 and notified investors on the New York Stock Exchange. The article says Clearwater UK will use KeyCorp’s expertise for corporate finance advisory services.

$KEYMed

KeyCorp Q2 2026 Earnings Call Summary

KeyCorp’s Q2 2026 earnings call cited 3% sequential commercial loan growth, net interest margin expansion to 2.89%, and 12% growth in commercial payments fees. Management raised full-year revenue guidance to 7-8% growth and projected NIM of 3.0% to 3.05% by year-end, plus $1.3B+ in 2026 buybacks.